Publikationen

Publications: 365 original articles in peer-reviewed journals (www.pubmed.org)

Impact Factor: >1.950

Cumulative Citations: 12.562

Average Citation Index: 32,21

h-index: 42

 

Die 10 relevantesten Publikationen

  1. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 score in 1,478 postmenopausal patients of the ABCSG-08 trial treated with adjuvant endocrine therapy alone
    Ann Oncol 2014; 25: 339-45
    IF: 7,384
  2. Everolimus reduced bone marker levels and progressive disease in bone in BOLERO-2
    J Nat Cancer Inst 2013; 105: 654-63
    IF: 14,336
  3. Distal gastrectomy in pancreaticoduodenectomy is associated with accelerated gastric emptying, enhanced postprandial release of GLP-1, and improved insulin sensitivity
    J Gastrointest Surg 2014; 18: 52-9
    IF: 2,361
  4. Preparing for prospective clinical trials – a national initiative of an excellence registry for consecutive pancreatic cancer resections
    Surgery 2014; 38: 456-62
    IF: 3,373
  5. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer
    N Eng J Med 2012; 366: 520-9
    IF: 53,298
  6. Dual HER2 inhibition in breast cancer treatment
    Lancet 2012; 379: 432-44
    IF: 39.060
  7. Targeted therapies: Adjuvant bisphosphonates – an option with low estrogen?
    Nature Reviews Clinical Oncology 2011; 8: 698-9
    IF: 11,963
  8. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer mortality in women with early breast cancer: analysis of individual patient data on 10,801 women in 17 randomised trials
    Lancet 2011; 378: 1707-16
    IF: 38,278
  9. Adjuvant endocrine therapy plus zoledronic acid in premenopausal breast cancer
    New Engl J Med 2009; 360:679-91
    IF: 52,589
  10. Fighting overtreatment in adjuvant breast cancer therapy
    Lancet 2009; 374: 2029-30
    IF: 30,758

 

Liste der Publikationen zum Download